21 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
support and oversight of patient eligibility. Dr. François was the national coordinator for numerous emergency trials, especially in sepsis, and has
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (“PCAOB”), (ii) stating
6-K
EX-99.1
lz10fpf8ao154xolg
2 Aug 21
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant
8:02am
6-K
EX-1.1
kwce2 mqje
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
20-F/A
ilfqojm2
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.4
y00v2i7i
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.3
faz51
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
oeum exrkea6ehw8h39
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
20-F
7cwiocz 89q4
31 Mar 15
Annual report (foreign)
12:00am
424B4
s6ngth61px wx
31 Jul 14
Prospectus supplement with pricing info
12:00am